Found 61 matching trials
Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia PHASE2 The goal of this clinical trial is to evaluate whether inhaled Treprostinil...
Show More Location
Duke Asthma Allergy and Airway Center
Learn More & Join Trial
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching N/A The purpose of this study is to see how inhaled treprostinil sodium (Tyvaso...
Show More Location
University of Florida, Jacksonville
Learn More & Join Trial
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies N/A A surveillance of respiratory tract related adverse events in patients trea...
Show More Location
Cardiovascular Associates, P.C.
Learn More & Join Trial
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) PHASE2 The primary objective of this study is to evaluate the safety and tolerabil...
Show More Learn More & Join Trial
Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension PHASE2 This study aims to evaluate the efficacy and safety of inhaled treprostinil...
Show More Location
University of Florida, Division of Pulmonary and Critical Care Medicine
Learn More & Join Trial
Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment N/A Fibrosing interstitial lung diseases (FILDs) encompass a group of rare dise...
Show More Location
Hôpital Cardiologique et Pneumologique Louis Pradel
Learn More & Join Trial
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE PHASE2 This is a multicenter, open-label trial to evaluate the safety and efficacy...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects PHASE4 This is a 24-month, multi-center, prospective, open-label, safety evaluatio...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH) PHASE2 The primary purpose of the study is to evaluate the safety and tolerability...
Show More Status
Active Not Recruiting
Learn More & Join Trial
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH N/A Study LTI-401 is an open-label, multicenter study which will evaluate the s...
Show More Location
Arizona Pulmonary Specialists
Learn More & Join Trial